Abstract
Myeloid derived suppressor cells (MDSCs) are heterogeneous subsets of immune cells and they function to inhibit host T cells activation leading to tumour growth. Currently, the majority of studies support key contributions of MDSCs to tumour progression via direct mechanisms immune mediated and indirect mechanism which is not directly associated with immune suppression. Due to the complexity of MDSCs heterogeneity, the aspect of MDSCs phenotype, morphology and function is poorly investigated up to date. And for this reason, this review will provide a comprehensive understanding of the role and function of MDSCs in cancer patients. Targeting the immunosuppressive cells MDSCs may improve the efficacy of immunotherapy in cancer patients in future.
Publisher
Alasmarya Islamic University